Cardea secures international patent coverage for its pioneering work on developing mass-produced graphene biosensors – PR Newswire
SAN DIEGO, April 27, 2022 /PRNewswire/ — Today, Cardea Bio, Inc. – the world’s first mass producer of graphene biosensors – shares their continued success to secure broad intellectual property (IP) protection, via recently secured patents in South Korea, China, Europe in addition to existing patents in the United States.
Cardea’s rapidly expanding IP portfolio now has 28 broad patents issued and another 33 patents pending, cementing Cardea’s market-leader position in the graphene biosensor industry, where they are bringing the BPU (Biosignal Processing Unit) Platform to market.
“In the world of graphene biosensors and bioelectronics, most of the sensors and instruments are made to measure one or a few biological elements. However, our liquid-gated graphene Field Effect Transistors (gFET) – what we call a Biosignal Processing Unit (BPU) – is an extremely versatile platform that allows all kinds of biosignals to be measured on the sensor, so we can electronically translate different…
The post Cardea secures international patent coverage for its pioneering work on developing mass-produced graphene biosensors – PR Newswire first appeared on SEO, Marketing and Social News | OneSEOCompany.com.
source: https://news.oneseocompany.com/2022/04/27/cardea-secures-international-patent-coverage-for-its-pioneering-work-on-developing-mass-produced-graphene-biosensors-pr-newswire_2022042718694.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.